EUCTR2020-001448-24-GBActive, not recruitingPhase 1
Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19 - COVIDSurgRCT_v1.0_20200330
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- niversity of Birmingham
- Enrollment
- 6,400
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Testing and criteria for diagnosis COVID-19 is likely to rapidly evolve over the course of this trial and will vary internationally. Therefore, the following pragmatic definitions will be applied:
- •Confirmed positive test for COVID-19: either a laboratory test (performed according to each participating hospital’s local protocols) or a computed tomography (CT) thorax scan (based on individual radiologist interpretation and diagnosis) that confirms COVID-19 diagnosis.
- •Confirmed negative test for COVID-19: a laboratory test (performed according to each participating hospital’s local protocols) that is negative for COVID-19 diagnosis.
- •Patients are eligible for the study if ALL of the following apply:
- •-Aged 18 years or above
- •-Planned to undergo any type of elective or emergency inpatient surgery requiring general or regional anaesthesia (such as vulnerable patients undergoing surgery for a fractured neck of femur)
- •-Asymptomatic of COVID-19, including patients with: those not tested, negative test results, postive test but no symptoms
- •-Able to provide informed patient consent
- •The eligibility criteria may change over time to reflect new diagnostic tests or changing epidemiology. This will be reviewed regularly by the Trial Management Group and Data Monitoring Committee. For example, if routine serological screening before surgery becomes feasible during the course of the trial in any participating hospital, only seronegative patients may be eligible for the trial.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 1000
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 4400
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 1000
Exclusion Criteria
- •Patients are not eligible for the study if ANY of the following apply:
- •--Procedures under local anaesthesia
- •-Symptomatic COVID-19 infection (by confirmed COVID-19 test or a clinical diagnosis); these patients will be eligible for the RECOVERY trial.
- •-Existing regular preoperative treatment with trial drugs
- •-Known history of adverse reaction/contraindication to trial drugs
- •-Pregnancy (including caesarean section)
- •It is anticipated that very few patients listed for surgery will have symptomatic COVID-19 infection at the time of surgery, and although any such patients will be excluded from this trial, they will be eligible for the parallel RECOVERY trial.
Investigators
Similar Trials
Unknown
Phase 3
Prevention of Respiratory Complications In At Surgery in COVID-19 PandemicCTRI/2020/06/026196niversity Of Birmingham
Not yet recruiting
Not Applicable
Prevention of Perioperative Pulmonary Complications by Lung Recruitment During Laparoscopic Surgery in Trendelenburg Head-down PositioPerioperative ComplicationJPRN-UMIN000043252Department of Anesthesiology and Intensive Care Medicine, Osaka University80
Not yet recruiting
Unknown
Prevention of pulmonary complications after major abdominal surgery using smartphone app-based spirometry equipment in geriatric populatioDiseases of the respiratory systemKCT0008460Bundang CHA General Hospital82
Completed
Not Applicable
Prediction of pulmonary complications after surgery for lung cancer, using skeletal muscle massNeoplasmsKCT0007474Konkuk University Medical Center200
Not yet recruiting
Not Applicable
Postoperative Pulmonary Complications: Incidence and risk factors in patients undergoing major abdominal cancer surgeryCTRI/2018/07/014946Tata Memorial Hospital